Divisions of Preventive Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA.
Clin Chem. 2011 Aug;57(8):1178-87. doi: 10.1373/clinchem.2011.167544. Epub 2011 Jun 23.
Abnormalities in traditional lipids, particularly decreased HDL cholesterol and increased triglycerides, can precede the onset of hypertension. Whether lipoprotein particle size or subclass concentrations play a role in the development of hypertension is unknown.
We followed 17 527 initially healthy women without baseline hypertension prospectively for 8 years. At baseline, information regarding traditional lipids and hypertension risk factors was obtained, and lipoprotein size and subclass concentrations were measured by nuclear magnetic resonance spectroscopy.
Baseline lipoprotein size and subclass concentrations were significantly associated with incident hypertension. Although LDL cholesterol was not associated with hypertension [odds ratio (OR) for quintile 5 vs 1: 1.08 (95% CI 0.96-1.20)], increased concentrations of LDL particles were associated with greater risk [OR 1.73 (1.54-1.95)], especially small LDL particles [OR 1.62 (1.45-1.83)]. Increased HDL cholesterol was associated with lower risk of hypertension [OR for quintile 5 vs 1: 0.79 (0.70-0.89)]. By contrast, increased concentrations of HDL particles had greater risk [OR 1.48 (1.32-1.67)], especially small HDL particles [OR 1.36 (1.22-1.53)], whereas large HDL particles had lower risk [OR 0.80 (0.71-0.90)]. Triglycerides and triglyceride-rich VLDL particles were positively associated with hypertension, with large VLDL particles associated with greater risk [OR 1.68 (1.50-1.89)]. Adding particle subclasses improved discrimination over a model with traditional lipids and risk factors (c-statistic 0.671 compared to 0.676; P < 0.001).
In this study of initially healthy women, lipoprotein particle size and subclass concentrations were associated with incident hypertension and provided additive information to traditional lipids and risk factors.
传统脂质异常,特别是高密度脂蛋白胆固醇降低和甘油三酯升高,可能先于高血压的发生。脂蛋白颗粒大小或亚类浓度在高血压的发展中是否起作用尚不清楚。
我们前瞻性地随访了 17527 名最初无基线高血压的健康女性,随访时间为 8 年。基线时,我们获取了有关传统脂质和高血压危险因素的信息,并通过核磁共振光谱法测量了脂蛋白颗粒大小和亚类浓度。
基线脂蛋白颗粒大小和亚类浓度与新发高血压显著相关。虽然 LDL 胆固醇与高血压无关(五分位 5 与 1 的比值比:1.08(95%可信区间:0.96-1.20)),但 LDL 颗粒浓度的增加与更大的风险相关(比值比 1.73(1.54-1.95)),尤其是小 LDL 颗粒(比值比 1.62(1.45-1.83))。HDL 胆固醇升高与高血压风险降低相关(五分位 5 与 1 的比值比:0.79(0.70-0.89))。相比之下,HDL 颗粒浓度的增加与更大的风险相关(比值比 1.48(1.32-1.67)),尤其是小 HDL 颗粒(比值比 1.36(1.22-1.53)),而大 HDL 颗粒则与较低的风险相关(比值比 0.80(0.71-0.90))。甘油三酯和富含甘油三酯的 VLDL 颗粒与高血压呈正相关,大 VLDL 颗粒与更大的风险相关(比值比 1.68(1.50-1.89))。与包含传统脂质和危险因素的模型相比,添加颗粒亚类可提高对高血压的判别能力(c 统计量为 0.671 比 0.676;P<0.001)。
在这项对最初健康女性的研究中,脂蛋白颗粒大小和亚类浓度与新发高血压相关,并为传统脂质和危险因素提供了附加信息。